QuantHealth raises $45 million Series B led by Qumra Capital to enhance AI simulations in clinical trials. The funding will support R&D and workforce expansion.
Amount Raised
$45 Million
Round Type
Series B
Tel AvivBiotechnologyHealth CareresearchInvestors
Description
QuantHealth, which develops AI-based simulations for clinical trials, has raised $45 million in a Series B funding round led by growth fund Qumra Capital. The latest round aims to expand its research and development capabilities and broaden its therapeutic coverage. Founded in 2020, QuantHealth employs approximately 85 people. The company is based in both New York and Tel Aviv.
Quick answer
QuantHealth raised $45 Million in a Series B round, dated August 4, 2026. Investors: Pitango HealthTech, NewHealth Ventures, Gc Ventures, Artofin Venture Capital Fund L.P., Sanofi Ventures, Shoni Top Ventures, Esplanade Ventures and Bertelsmann Healthcare Investments. QuantHealth is based in Tel Aviv, Tel Aviv District, Israel.
- How much did QuantHealth raise?
- QuantHealth raised $45 Million in a Series B round on August 4, 2026.
- Who invested in QuantHealth?
- Pitango HealthTech, NewHealth Ventures, Gc Ventures, Artofin Venture Capital Fund L.P., Sanofi Ventures, Shoni Top Ventures, Esplanade Ventures and Bertelsmann Healthcare Investments are named as investors in this round.
- What does QuantHealth do?
- QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development.
- Where is QuantHealth based and how big is it?
- QuantHealth is based in Tel Aviv, Tel Aviv District, Israel. Fundz records about 62 employees.
- Who are the decision-makers at QuantHealth?
- Fundz holds 1 contact at QuantHealth. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as QuantHealth that raised within 45 days of this round, from Fundz verified event records.
- BioLineRx Ltd raised $3.8M on August 27, 2026.
- Expedition Therapeutics raised $115M (Series B) on August 5, 2026.
- Draig Therapeutics raised $65M (Series B) on July 14, 2026.
- Grail raised $110M (Post-IPO Equity) on June 25, 2026.
- Big Picture Bio raised $2M (Pre-Seed) on September 18, 2026.
- Phosphoenix raised $1.5M (Seed) on September 18, 2026.
Who to call at QuantHealth, and when
A new round usually means QuantHealth is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day QuantHealth raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at QuantHealth, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at QuantHealth. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment QuantHealth raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansQuantHealth raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.